Levobunolol

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Levobunolol
Levobunolol.svg
Clinical data
Trade names Betagan
AHFS/Drugs.com Monograph
MedlinePlus a686011
Pregnancy
category
  • C
Routes of
administration
Topical (eye drops)
ATC code
Legal status
Legal status
Pharmacokinetic data
Biological half-life 20 hours
Identifiers
CAS Number
PubChem CID
IUPHAR/BPS
DrugBank
ChemSpider
UNII
KEGG
ChEBI
ChEMBL
Chemical and physical data
Formula C17H25NO3
Molar mass 291.385 g/mol
3D model (Jmol)
 NYesY (what is this?)  (verify)

Levobunolol (AK-Beta, Liquifilm, Betegan) is a non-selective beta blocker. It is used topically to manage glaucoma.

References[edit]

  • Ishibashi T, Yokoi N, Kinoshita S (2003). "Comparison of the effects of topical levobunolol and timolol solution on the human ocular surface.". Cornea. 22 (8): 709–15. doi:10.1097/00003226-200311000-00001. PMID 14576520. 
  • Ogasawara H, Yoshida A, Fujio N, Konno S, Ishiko S (1999). "[Effect of topical levobunolol on retinal, optic nerve head, and choroidal circulation in normal volunteers]". Nippon Ganka Gakkai Zasshi. 103 (7): 544–50. PMID 10443129. 
  • Leung M, Grunwald J (1997). "Short-term effects of topical levobunolol on the human retinal circulation.". Eye. 11 (3): 371–6. doi:10.1038/eye.1997.78. PMID 9373479.